Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Short-term Investments (2018 - 2019)

Apyx Medical (APYX) has disclosed Short-term Investments for 6 consecutive years, with $40.9 million as the latest value for Q1 2019.

  • For the quarter ending Q1 2019, Short-term Investments changed N/A year-over-year to $40.9 million, compared with a TTM value of $40.9 million through Mar 2019, changed N/A, and an annual FY2018 reading of $61.7 million, changed N/A over the prior year.
  • Short-term Investments was $40.9 million for Q1 2019 at Apyx Medical, down from $61.7 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $61.7 million in Q4 2018 and bottomed at $172000.0 in Q3 2015.
  • Average Short-term Investments over 3 years is $26.5 million, with a median of $20.6 million recorded in 2015.
  • Peak annual rise in Short-term Investments hit 23.89% in 2015, while the deepest fall reached 23.89% in 2015.
  • Year by year, Short-term Investments stood at $172000.0 in 2015, then surged by 35759.3% to $61.7 million in 2018, then plummeted by 33.71% to $40.9 million in 2019.
  • Business Quant data shows Short-term Investments for APYX at $40.9 million in Q1 2019, $61.7 million in Q4 2018, and $55.5 million in Q3 2018.